Cytek Biosciences Inc (CTKB) — Financial Flexibility Index
Cytek Biosciences Inc (CTKB) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-568.00K (operating CF $-2.74 Million minus capex $2.17 Million) represents 0% of total liabilities ($121.47 Million). Check Cytek Biosciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytek Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Cytek Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see CTKB cash flow metrics.
Annual Financial Flexibility Index for Cytek Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Cytek Biosciences Inc. Explore Cytek Biosciences Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-602.00K | $-4.69 Million | $119.80 Million | ▼ -101.8% |
| 2024 | 0.28x | $28.90 Million | $25.38 Million | $103.76 Million | ▲ +179.4% |
| 2023 | 0.10x | $10.11 Million | $5.28 Million | $101.39 Million | ▲ +496.3% |
| 2022 | -0.03x | $-2.36 Million | $-12.23 Million | $93.93 Million | ▼ -116.2% |
| 2021 | 0.16x | $8.99 Million | $4.63 Million | $57.92 Million | ▲ +119.4% |
| 2020 | 0.07x | $16.70 Million | $15.16 Million | $236.01 Million | ▲ +162.1% |
| 2019 | -0.11x | $-12.77 Million | $-13.75 Million | $112.06 Million | — |